Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of vasopressin and norepinephrine on renal function in CABG patients
IRCT201412054256N4Phase 2Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of vasopressin and norepinephrine in coronary arteriosclerosis (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Renal function. Started Jan 2015; status: completed.
02
Drugs
vasopressinnorepinephrine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201412054256N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201412054256N4.